Revance Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Revance Therapeutics shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.0M | 3.5M | 0.85 |
| 2023-12-31 | $380k | 500k | 0.76 |
| 2023-09-30 | $402k | 500k | 0.80 |
| 2023-03-31 | $675k | 550k | 1.23 |
| 2022-12-31 | $23k | 25k | 0.91 |